Source: Sharecast
It also raised its guidance for full-year operating profit margins.
The life-saving technology outfit said that it was now anticipating a full-year adjusted EBIT margin "modestly above" 21%, versus a prior forecast for a margin of around 21%.
Trading conditions across its end markets were described as "varied".
Order intake remained ahead of revenues year-to-date and versus the year earlier period.
Halma also said that its adjusted EBIT margins had been supported by a better-than-expected performance in all three of the sectors in which it operated.
Management also reiterated its forecast for "good" organic constant currency revenue growth for the full year.
Strength in Sterling was expected to drag on the group's results.
The acquisition pipeline across all three of its sectors was described as still "healthy" and cash conversion for the full-year was expected to be "strong".